<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Hypoproliferative | HE</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Audio Overview     Overview of Hypoproliferative Anemias  Definition: A group of anemias characterized by a decreased production of red blood cells (RBCs) by the bone marrow. This is due to a...">
<meta name="generator" content="bookdown 0.43 with bs4_book()">
<meta property="og:title" content="Hypoproliferative | HE">
<meta property="og:type" content="book">
<meta property="og:description" content="Audio Overview     Overview of Hypoproliferative Anemias  Definition: A group of anemias characterized by a decreased production of red blood cells (RBCs) by the bone marrow. This is due to a...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Hypoproliferative | HE">
<meta name="twitter:description" content="Audio Overview     Overview of Hypoproliferative Anemias  Definition: A group of anemias characterized by a decreased production of red blood cells (RBCs) by the bone marrow. This is due to a...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><link rel="icon" type="image/png" href="imgs/favicon.png">
<meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
<link rel="stylesheet" href="toc.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="active" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary-1.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="hypoproliferative" class="section level1 unnumbered">
<h1>Hypoproliferative<a class="anchor" aria-label="anchor" href="#hypoproliferative"><i class="fas fa-link"></i></a>
</h1>
<div id="3c683220636c6173733d226e6f2d737469636b223e" class="section level2 unnumbered">
<h2 class="no-stick">
<strong>Audio Overview</strong>
<a class="anchor" aria-label="anchor" href="#3c683220636c6173733d226e6f2d737469636b223e"><i class="fas fa-link"></i></a>
</h2>
<center>
<iframe allow="autoplay *; encrypted-media *; fullscreen *; clipboard-write" frameborder="0" height="175" style="width:100%;max-width:660px;overflow:hidden;border-radius:10px;" sandbox="allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation" src="https://embed.podcasts.apple.com/us/podcast/hypoproliferative/id1780125002?i=1000716370069">
</iframe>
</center>
</div>
<div id="overview-of-hypoproliferative-anemias" class="section level2 unnumbered">
<h2>
<strong>Overview of Hypoproliferative Anemias</strong><a class="anchor" aria-label="anchor" href="#overview-of-hypoproliferative-anemias"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> A group of anemias characterized by a <em>decreased</em> production of red blood cells (RBCs) by the bone marrow. This is due to a problem with the bone marrow’s ability to produce RBCs, despite adequate nutrients (like iron, vitamin B12, and folate)</li>
<li>
<strong>Hallmark:</strong> A <em>low</em> reticulocyte count (corrected reticulocyte count or reticulocyte production index) in the setting of anemia. This indicates that the bone marrow is <em>not</em> responding appropriately to the anemia by increasing RBC production</li>
<li>
<strong>Key Feature:</strong> Reduced erythropoiesis (RBC production) in the bone marrow</li>
<li>
<strong>Classification:</strong>
<ul>
<li>
<strong>Primary Bone Marrow Disorders:</strong> Intrinsic problems within the bone marrow itself (e.g., aplastic anemia, myelodysplastic syndromes)</li>
<li>
<strong>Secondary Causes:</strong> Extrinsic factors that suppress erythropoiesis (e.g., chronic kidney disease, endocrine disorders, anemia of chronic disease)</li>
</ul>
</li>
</ul>
</div>
<div id="key-concepts" class="section level2 unnumbered">
<h2>
<strong>Key Concepts</strong><a class="anchor" aria-label="anchor" href="#key-concepts"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Reticulocyte Response:</strong> In a normal, healthy individual with anemia, the bone marrow should respond by increasing RBC production, leading to an <em>elevated</em> reticulocyte count. In hypoproliferative anemias, this response is <em>absent</em> or <em>inadequate</em>
</li>
<li>
<strong>Bone Marrow Examination:</strong> A bone marrow aspiration and biopsy is often <em>essential</em> for diagnosing hypoproliferative anemias, as it provides direct information about the cellularity and maturation of the bone marrow</li>
<li>
<strong>Exclusion of Other Causes:</strong> It’s important to rule out other causes of anemia (e.g., blood loss, hemolysis, nutritional deficiencies) <em>before</em> diagnosing a hypoproliferative anemia</li>
</ul>
</div>
<div id="causes-of-hypoproliferative-anemias" class="section level2 unnumbered">
<h2>
<strong>Causes of Hypoproliferative Anemias</strong><a class="anchor" aria-label="anchor" href="#causes-of-hypoproliferative-anemias"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Primary Bone Marrow Disorders:</strong>
<ul>
<li>
<strong>Aplastic Anemia (AA):</strong>
<ul>
<li>
<strong>Definition:</strong> Bone marrow failure characterized by <em>pancytopenia</em> (decreased RBCs, WBCs, and platelets) and a <em>hypocellular</em> bone marrow</li>
<li>
<strong>Etiology:</strong> Can be acquired (idiopathic, autoimmune, drug-induced, radiation-induced, infection-related) or inherited (e.g., Fanconi anemia)</li>
<li>
<strong>Pathophysiology:</strong> Damage to or destruction of hematopoietic stem cells (HSCs) in the bone marrow, leading to reduced production of all blood cell lines</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Anemia (fatigue, weakness, pallor)</li>
<li>Thrombocytopenia (bleeding, bruising)</li>
<li>Neutropenia (increased susceptibility to infections)</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC: Pancytopenia (low HGB, HCT, RBC count, WBC count, and platelet count)</li>
<li>Peripheral Blood Smear: Normocytic, normochromic RBCs; absence of abnormal cells</li>
<li>Reticulocyte Count: Very low (hallmark finding)</li>
<li>Bone Marrow Examination: Hypocellular marrow with decreased or absent hematopoietic cells</li>
<li>Flow cytometry: May show decreased or abnormal hematopoietic stem cells</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Supportive care:
<ul>
<li>Transfusions (RBCs and platelets) to alleviate symptoms</li>
<li>Antibiotics to treat infections</li>
</ul>
</li>
<li>Immunosuppressive Therapy:
<ul>
<li>To suppress the autoimmune attack on bone marrow stem cells</li>
<li>Antithymocyte globulin (ATG)</li>
<li>Cyclosporine</li>
</ul>
</li>
<li>Hematopoietic Stem Cell Transplantation (HSCT):
<ul>
<li>Potentially curative option, especially for younger patients with matched donors</li>
<li>Involves replacing the patient’s damaged bone marrow with healthy stem cells from a donor</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Myelodysplastic Syndromes (MDS):</strong>
<ul>
<li>
<strong>Definition:</strong> A group of clonal hematopoietic stem cell disorders characterized by <em>ineffective hematopoiesis</em> and a variable risk of progression to acute myeloid leukemia (AML)</li>
<li>
<strong>Etiology:</strong> Acquired mutations in hematopoietic stem cells
<ul>
<li>Risk factors: Advanced age, exposure to certain chemicals or radiation, prior chemotherapy or radiation therapy</li>
</ul>
</li>
<li>
<strong>Pathophysiology:</strong> Dysplastic (abnormal) development of one or more myeloid cell lines (RBCs, WBCs, platelets), leading to cytopenias and increased risk of AML</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Anemia (fatigue, weakness, pallor)</li>
<li>Thrombocytopenia (bleeding, bruising)</li>
<li>Neutropenia (infections)</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC: Cytopenias (anemia, thrombocytopenia, leukopenia)</li>
<li>Peripheral Blood Smear: Dysplastic features in one or more cell lines
<ul>
<li>RBCs: Oval macrocytes, hypochromia, basophilic stippling</li>
<li>Neutrophils: Pseudo-Pelger-Huët anomaly (bi-lobed neutrophils), hypogranulation</li>
<li>Platelets: Large platelets, abnormal granulation</li>
</ul>
</li>
<li>Reticulocyte Count: Low or normal (inappropriately low for the degree of anemia)</li>
<li>Bone Marrow Examination: Hypercellular or hypocellular marrow with dysplasia in one or more cell lines</li>
<li>Cytogenetic Analysis: Chromosomal abnormalities (e.g., deletion 5q, trisomy 8) are common</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Supportive care:
<ul>
<li>Transfusions to manage anemia and thrombocytopenia</li>
<li>Growth factors (e.g., erythropoietin, G-CSF) to stimulate blood cell production</li>
<li>Antibiotics to treat infections</li>
</ul>
</li>
<li>Hypomethylating Agents:
<ul>
<li>Azacitidine and decitabine: Improve hematopoiesis and reduce the risk of AML transformation</li>
</ul>
</li>
<li>Lenalidomide:
<ul>
<li>Used for patients with MDS with deletion 5q</li>
</ul>
</li>
<li>Hematopoietic Stem Cell Transplantation (HSCT):
<ul>
<li>Potentially curative option for younger patients with high-risk MDS</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Pure Red Cell Aplasia (PRCA):</strong>
<ul>
<li>
<strong>Definition:</strong> Selective destruction of erythroid precursors in the bone marrow, leading to severe anemia with a <em>marked</em> decrease in reticulocytes</li>
<li>
<strong>Etiology:</strong>
<ul>
<li>Acquired:
<ul>
<li>Autoimmune: Antibodies against erythroid precursors or erythropoietin</li>
<li>Infections: Parvovirus B19 infection (especially in patients with chronic hemolytic anemias)</li>
<li>Drug-induced: Certain medications (e.g., erythropoietin, immunosuppressants)</li>
<li>Thymoma: Tumor of the thymus gland</li>
</ul>
</li>
<li>Inherited: Diamond-Blackfan anemia</li>
</ul>
</li>
<li>
<strong>Pathophysiology:</strong>
<ul>
<li>Autoantibodies or cytotoxic T cells target and destroy erythroid precursors (CFU-Es and proerythroblasts) in the bone marrow</li>
<li>Parvovirus B19 directly infects and destroys erythroid precursors</li>
</ul>
</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Severe anemia</li>
<li>Absence of other cytopenias (normal WBC and platelet counts)</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>CBC: Severe anemia with normal WBC and platelet counts</li>
<li>Peripheral Blood Smear: Normocytic, normochromic RBCs; absence of abnormal cells</li>
<li>Reticulocyte Count: Very low (near zero)</li>
<li>Bone Marrow Examination: Normal cellularity with a marked decrease or absence of erythroid precursors</li>
<li>Antibody Testing: May detect antibodies against erythroid precursors or erythropoietin</li>
<li>Parvovirus B19 PCR: To detect parvovirus B19 infection</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Treat Underlying Cause:
<ul>
<li>Discontinue offending medications</li>
<li>Treat infections (e.g., parvovirus B19)</li>
<li>Remove thymoma (if present)</li>
</ul>
</li>
<li>Immunosuppressive Therapy:
<ul>
<li>Corticosteroids</li>
<li>Cyclosporine</li>
</ul>
</li>
<li>Intravenous Immunoglobulin (IVIG):
<ul>
<li>May be used in parvovirus B19-related PRCA</li>
</ul>
</li>
<li>Blood Transfusions:
<ul>
<li>To manage severe anemia</li>
</ul>
</li>
<li>Erythropoiesis-Stimulating Agents (ESAs):
<ul>
<li>May be effective in some cases, especially if EPO levels are low</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Secondary Causes of Hypoproliferative Anemia:</strong>
<ul>
<li>
<strong>Chronic Kidney Disease (CKD):</strong>
<ul>
<li>Decreased erythropoietin (EPO) production by the kidneys</li>
<li>Uremic toxins can also suppress erythropoiesis</li>
<li>Treatment:
<ul>
<li>Erythropoiesis-stimulating agents (ESAs)</li>
<li>Iron supplementation</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Endocrine Disorders:</strong>
<ul>
<li>Hypothyroidism: Decreased thyroid hormone can reduce erythropoiesis</li>
<li>Hypopituitarism: Decreased production of hormones that stimulate erythropoiesis (e.g., growth hormone, androgens)</li>
<li>Treatment: Hormone replacement therapy</li>
</ul>
</li>
<li>
<strong>Anemia of Chronic Disease/Inflammation:</strong>
<ul>
<li>Chronic inflammation leads to increased hepcidin production, which impairs iron release and reduces erythropoiesis</li>
<li>Treatment:
<ul>
<li>Treat underlying inflammatory condition</li>
<li>Erythropoiesis-stimulating agents (ESAs) (use cautiously)</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Nutritional Deficiencies (Less Common Cause of Hypoproliferative Anemia):</strong>
<ul>
<li>Severe protein-calorie malnutrition</li>
<li>Scurvy (vitamin C deficiency)</li>
<li>These deficiencies primarily affect RBC maturation but can also impair erythropoiesis</li>
<li>Treatment: Correct the underlying nutritional deficiency</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="key-laboratory-findings-in-hypoproliferative-anemias" class="section level2 unnumbered">
<h2>
<strong>Key Laboratory Findings in Hypoproliferative Anemias</strong><a class="anchor" aria-label="anchor" href="#key-laboratory-findings-in-hypoproliferative-anemias"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Complete Blood Count (CBC):</strong>
<ul>
<li>Anemia (low HGB and HCT)</li>
<li>MCV: Can be normocytic, microcytic, or macrocytic, depending on the underlying cause</li>
</ul>
</li>
<li>
<strong>Peripheral Blood Smear:</strong>
<ul>
<li>RBC morphology: Usually normocytic and normochromic, but may show abnormalities depending on the cause (e.g., oval macrocytes in MDS)</li>
</ul>
</li>
<li>
<strong>Reticulocyte Count:</strong>
<ul>
<li>Low (hallmark finding)</li>
</ul>
</li>
<li>
<strong>Iron Studies:</strong>
<ul>
<li>Variable, depending on the underlying cause</li>
</ul>
</li>
<li>
<strong>Serum Erythropoietin (EPO) Level:</strong>
<ul>
<li>May be low, normal, or elevated, depending on the underlying cause</li>
</ul>
</li>
<li>
<strong>Bone Marrow Examination:</strong>
<ul>
<li>Essential for diagnosis</li>
<li>Cellularity: Can be hypocellular (aplastic anemia) or normocellular/hypercellular (MDS)</li>
<li>Maturation: May show dysplastic features (MDS) or a selective decrease in erythroid precursors (PRCA)</li>
<li>Cytogenetics: To detect chromosomal abnormalities in MDS</li>
<li>Special stains and flow cytometry: To evaluate for specific abnormalities</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-12" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-12"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Hypoproliferative Anemia:</strong> Anemia due to decreased red blood cell production</li>
<li>
<strong>Aplastic Anemia:</strong> Bone marrow failure with pancytopenia and hypocellular marrow</li>
<li>
<strong>Myelodysplastic Syndromes (MDS):</strong> Clonal hematopoietic stem cell disorders with ineffective hematopoiesis</li>
<li>
<strong>Pure Red Cell Aplasia (PRCA):</strong> Selective destruction of erythroid precursors in the bone marrow</li>
<li>
<strong>Reticulocyte Count:</strong> Measure of new red blood cell production</li>
<li>
<strong>Bone Marrow Examination:</strong> Aspiration and biopsy to assess the cellularity and maturation of blood cell precursors</li>
<li>
<strong>Erythropoietin (EPO):</strong> Hormone that stimulates red blood cell production</li>
<li>
<strong>Cytopenia:</strong> Deficiency of blood cells (e.g., anemia, neutropenia, thrombocytopenia)</li>
<li>
<strong>Dysplasia:</strong> Abnormal cell development</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? l.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="acquired-hemolytic.html">Acquired Hemolytic</a></div>
<div class="next"><a href="acute-hemorrhage.html">Acute Hemorrhage</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#hypoproliferative">Hypoproliferative</a></li>
<li><a class="nav-link" href="#overview-of-hypoproliferative-anemias">Overview of Hypoproliferative Anemias</a></li>
<li><a class="nav-link" href="#key-concepts">Key Concepts</a></li>
<li><a class="nav-link" href="#causes-of-hypoproliferative-anemias">Causes of Hypoproliferative Anemias</a></li>
<li><a class="nav-link" href="#key-laboratory-findings-in-hypoproliferative-anemias">Key Laboratory Findings in Hypoproliferative Anemias</a></li>
<li><a class="nav-link" href="#key-terms-12">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/blob/main/Rmd/01-04-10-erythrocyte-normocytic-hypoproliferative.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/blob/edit/main/Rmd/01-04-10-erythrocyte-normocytic-hypoproliferative.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->


</body>
</html>
